Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Papua New Guinea records five new deaths from COVID-19

Published 18/03/2021, 05:47 pm
Updated 18/03/2021, 05:48 pm

SYDNEY, March 18 (Reuters) - Papua New Guinea has reported five new deaths and 128 new cases of COVID-19, as concern grows about low testing rates and surging cases threaten to overwhelm overstretched hospitals in the Pacific island nation.

Australia has pledged 8,000 doses of the AstraZeneca (NASDAQ:AZN) vaccine will be sent urgently to its northern neighbour to protect health workers. were airlifted from Australia by the Australian Defence Force on Wednesday to provide triage facilities for patients outside the Port Moresby General Hospital, where 100 staff are reported to have fallen ill, the ADF said.

Papua New Guinea's COVID-19 Pandemic National Response said on Thursday that total cases had risen to 2,479 by Tuesday, with the death toll reaching 31, more than doubling since the start of March.

Six out of eight new cases reported in Australia's northern state of Queensland were passengers arriving from Papua New Guinea before flights were suspended, said Queensland premier Annastacia Palaszczuk.

PNG health services have expressed concern at the spread of the disease among frontline health workers in already overstretched hospitals.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.